Overview
Bhadresh Nayak is a Hematologist Oncology specialist and a Hematologist in Sterling Heights, Michigan. Dr. Nayak is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Hereditary Resistance to Anti-Vitamin K, Congenital Antithrombin 3 Deficiency, Protein S Deficiency, Bone Marrow Aspiration, and Gastrostomy. Dr. Nayak is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MEDICARE MAPD
- MEDICARE SNP
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Henry Ford Health System
Asif Alavi is a Hematologist and a Hematologist Oncology provider in Detroit, Michigan. Dr. Alavi is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Sickle Cell Disease, Multiple Myeloma, Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), and Bone Marrow Transplant. Dr. Alavi is currently accepting new patients.
University Physician Group
Jay Yang is a Hematologist Oncology specialist and a Hematologist in Detroit, Michigan. Dr. Yang is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Acute Myeloid Leukemia (AML), Hairy Cell Leukemia (HCL), Reticuloendotheliosis, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Yang is currently accepting new patients.
University Physician Group
Andrew Kin is a Hematologist and a Hematologist Oncology provider in Detroit, Michigan. Dr. Kin is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Sickle Cell Disease, Acute Myeloid Leukemia (AML), and Bone Marrow Transplant. Dr. Kin is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Immune ThrombocytopeniaDr. Nayak isDistinguished. Learn about Adult Immune Thrombocytopenia.
- AnemiaDr. Nayak isDistinguished. Learn about Anemia.
- Childhood Iron Deficiency AnemiaDr. Nayak isDistinguished. Learn about Childhood Iron Deficiency Anemia.
- Congenital Antithrombin 3 DeficiencyDr. Nayak isDistinguished. Learn about Congenital Antithrombin 3 Deficiency.
- Drug-Induced ThrombocytopeniaDr. Nayak isDistinguished. Learn about Drug-Induced Thrombocytopenia.
- Essential ThrombocythemiaDr. Nayak isDistinguished. Learn about Essential Thrombocythemia.
- Advanced
- Adult Soft Tissue SarcomaDr. Nayak isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Nayak isAdvanced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Arterial EmbolismDr. Nayak isAdvanced. Learn about Arterial Embolism.
- B-Cell LymphomaDr. Nayak isAdvanced. Learn about B-Cell Lymphoma.
- Beta ThalassemiaDr. Nayak isAdvanced. Learn about Beta Thalassemia.
- Experienced
- Acquired AgranulocytosisDr. Nayak isExperienced. Learn about Acquired Agranulocytosis.
- Acquired HemophiliaDr. Nayak isExperienced. Learn about Acquired Hemophilia.
- Acute Arterial Occlusion of KidneyDr. Nayak isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Acute Eosinophilic PneumoniaDr. Nayak isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Nayak isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Nayak isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).